Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril for Painful Venous Malformations
NCT06788314Phase 2Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Feb 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enalapril in venous malformations (VM), sponsored by Oslo University Hospital. Primary endpoint: Change of venous malformation related pain at 12 months. Started Feb 2025; status: recruiting.
02
Drugs
enalapril
03
Conditions
venous malformations (VM)
Beyond the preview
Go deeper on NCT06788314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06788314.